Pear Therapeutics Inc (PEAR) Stock
PEAR is no longer traded. Pear Therapeutics was delisted from the Nasdaq in June 2023.
Prices on this page are historical; the last trade was June 20, 2023 at $0.01.
Pear Therapeutics stock price history
PEAR final trading statistics
- Final close
- $0.01
- Final trading day
- Jun 20, 2023
- Market cap at delisting
- $4.17M
- Shares outstanding
- 140.03M
- Final 52-week range
- $0.00 – $3.33
- Avg. volume (final 3 mo.)
- 10,777,345
- All-time high (split-adj.)
- $10.05 · Apr 2021
- All-time low (split-adj.)
- $0.00 · May 2023
- Return since IPO
- -99.9%
- Beta
- 0.52
- Book value / share
- $0.22
- Price / book
- 0.04
Pear Therapeutics annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2022 | $12.69M | -$23.7M | -$0.65 |
| FY2021 | $4.21M | $24.4M | -$0.63 |
| FY2020 | $9.38M | -$115.8M | — |
| FY2019 | $32.56M | $33.2M | — |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About Pear Therapeutics Inc
Pear Therapeutics, Inc., a commercial-stage healthcare company, develops and sells software-based medicines in the United States. Its commercial products are reSET for the treatment of substance use disorder related to alcohol, cannabis, cocaine, and stimulants; reSET-O for the treatment of opioid use disorder in combination with buprenorphine; and Somryst, a software-based treatment for chronic insomnia. The company is also developing a pipeline of product candidates focusing on psychiatry, neurology, and outside of central nervous system therapeutic areas, such as gastroenterology, cardiology, and oncology. Pear Therapeutics, Inc. was incorporated in 2013 and is headquartered in Boston, Massachusetts. On April 7, 2023, Pear Therapeutics, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Pear Therapeutics stock FAQ
What happened to Pear Therapeutics stock?
Pear Therapeutics stock was delisted from the Nasdaq. Its final close was $0.01 on June 20, 2023.
Is PEAR stock still trading?
No. PEAR was delisted from the Nasdaq in June 2023 and no longer trades on a U.S. exchange.
What was the last price of PEAR stock?
PEAR closed at $0.01 on its final trading day, June 20, 2023, for a market value of about $4.17M.
What were Pear Therapeutics's revenue and earnings in its last full fiscal year?
Pear Therapeutics reported revenue of $12.69M and net income of -$23.7M in fiscal 2022, its last full year as a public company.
When did Pear Therapeutics go public?
Pear Therapeutics Inc stock began trading on March 31, 2021.